<DOC>
	<DOCNO>NCT02583815</DOCNO>
	<brief_summary>This open label feasibility pilot study commercially available physical activity monitoring device patient receive systemic therapy Harold Simmons Cancer Center , UT Southwestern Medical Center .</brief_summary>
	<brief_title>Feasibility Activity Monitoring Patients With Cancer : Physical Activity Monitoring Cancer Patients ( PAMCaP )</brief_title>
	<detailed_description>Study conduct 12 week ( +/-14 day ) monitoring . BASELINE ASSESSMENTS Baseline assessment perform within 14 day Week 1 . 1 . Signed informed consent ; 2 . ECOG Performance Status per treat physician ( chart abstraction available data ) ; 3 . Pathology report confirm cancer diagnosis ; 4 . Psychosocial assessment questionnaire ; 5 . Blood correlative biomarkers ( 10 ml ) ; 6 . Documentation planned/ongoing chemotherapy regimen ON-STUDY ASSESSMENTS 1 . Physical Activity Monitor ( PAM ) 1 . Fitbit ( PAM ) device provide investigator period study ; 2 . Introduction device instruction use care provide base commercial marketing material ; 3 . Subjects assist set Fitbit device smart phone ; 4 . Subjects ask wear Fitbit device continuously 12 week - however , device wear bath showering ; 5 . Subjects ask sync Fitbit device database least week ; 6 . Clinical coordinator may send phone text reminder encourage sync Fitbit device record 1 week ' worth data ; 7 . Cost Coverage 8 . Investigators purchase device prior start study grant funding . 9 . PAM Accountability 10 . Investigator investigator site responsible maintain accurate inventory accountability logs device . 11 . Subjects ask sign form upon receipt return device applicable . 2 . ECOG - Eastern Cooperative Oncology Group Performance Status 0 - Fully active , able carry pre-disease performance without restriction ; 1 - Restricted physically strenuous activity ambulatory able carry work light sedentary nature , e.g. , light house work , office work ; 2 - Ambulatory capable self-care unable carry work activity . Up 50 % waking hour ; 3 - Capable limited self-care , confine bed chair 50 % waking hour ; 4 - Completely disable -- carry self-care . Totally confined bed chair ; 5 - Dead 3 . Functional Assessment Cancer Therapy - General ( FACT-G ) . . The FACT-G 27-item scale design measure multidimensional quality life breast cancer patient . 4 . Quick Inventory Depressive Symptomatology - Self-Rated ( QIDS-SR116 ) . . The QIDS-SR16 16-item version 30-item Inventory Depressive Symptomatology ( IDS ) design assess severity depression-specific symptom . 5 . Pittsburgh Sleep Quality Index ( PSQI ) ( See Appendix H ) .9 . The PSQI 19-item scale design assess sleep quality disturbance . 6 . Brief Fatigue Inventory ( BFI ) ( See Appendix I ) .10 . The BFI 9-item scale design assess fatigue cancer patient . 7 . Biomarker DNA Blood Tests 1 . Blood sample collect study visit indicate study calendar . Process sample accord sample processing instruction . Prior storage , complete sample inventory log subject specimen chain custody establish . Samples frozen −80°C time analysis ; 2 . Include shipment batch copy : 1 ) blood collection source document patient ; 2 ) copy subject specimen inventory form ; 3 . Keep original document subject 's chart ; 4 . Samples analyze use multiplexed ELISA method ( Meso Scale Discovery ) IL-1beta , IL-6 , IL-10 TNF-alpha ; 5 . With explicit participant consent , sample also process DNA store future analysis .</detailed_description>
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Urogenital Neoplasms</mesh_term>
	<mesh_term>Endocrine Gland Neoplasms</mesh_term>
	<criteria>Signed informed consent Age 18 Receiving planning receive outpatient therapy cancer Baseline ECOG status 02 ; Speak understand English Psychological assessment tool include study validate Spanish ; Access smartphone device compatible sync PAM Device Recent injury may result impaired mobility ; Major surgery within 4 week till recovery baseline functioning ( per patient ) whichever short ; Inability comply study requirement ; Medical , psychiatric condition investigator opinion affect successful completion study ; Current use wearable PAM device define use PAM device last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>